Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02479178
Title A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck (iNSITE2)
Acronym iNSITE2
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors BIND Therapeutics
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.